NLRP3 and atherosclerosis: Nucleotide-binding oligomerization domain-like receptor protein 3 (NLRP3) inflammasome activation has been shown to be a powerful mediator of inflammatory response via the release of the pro-inflammatory mediators interleukin-1β (IL) and IL-18 that boost lipid deposition, foam cell accumulation, and atherosclerosis progression [7].